On the clinical significance of the tumor-suppressor gene p53 in head and neck tumors;Zur klinischen bedeutung des tumorsuppressor-gens p53 bei Kopf-Hals- Tumoren

HNO

Volumn 45, Issue 9, 1997, Pages 659-663

  Preisler, V ^a   Kirchner, S ^b   Hagen, R ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

CARCINOGENESIS; HEAD AND NECK TUMOR; HUMAN; MALIGNANT TRANSFORMATION; PROGNOSIS; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030876177     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Bishop JM (1987) The molecular genetics of cancer. Science 235: 305-311
2. Brachman DG (1994) Molecular biology of head and neck cancer. Sem Oncol 21: 320-329
3. Brachman DG, Becket M, Graves D et al. (1993) p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 53: 3667-3669
4. Brachman DG, Graves D, Vokes E et al. (1992) Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 52:4832
5. Brennan JA, Mao I, Hruban RH et al. (1995) Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332: 429-435
6. Boyle JO, Hakim J, Koch W et al. (1993) The incidence of p53 mutation increases with progression of head and neck cancer. Cancer Res 53:4477-4480
7. Chang YS, Lin YJ, Tsai CN et al. (1992) Detection of mutations in the p53 gene in head and neck carcinomas by single strand conformation polymorphism analysis. Cancer Lett 67: 167-174
8. Chang F, Syranen S, Tervahauta A et al. (1993) Tumorgenesis associated with the p53 tumor suppressor gene. Br J Cancer 68: 654-661
9. Clayman GL, El-Naggar A, Roth JA et al. (1995) In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 55: 1-6
10. el Deiry WS, Harper JW, O'Connor PM et al. (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169-1174
11. Dolcetti R, Doglioni C, Maestro R et al.(1992) pS3 Over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications. Int J Cancer 52: 178-182
12. Field JK, Pavelic ZP, Spandidos DA et al. (1993) The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Acta Otolaryngol Head Neck Surg 119:1118-1122
13. Field JK, Spandidos DA, Malliri A et al. (1991) Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 63:573-577
14. Field JK, Spandidos DA, Stell PM (1992) Overexpression of the p53 gene in head and neck cancer, linked with heavy smoking. Lancet 339:502-503
15. Field JK, Zoumpourlis V, Spandidos DA et al. (1994) p53 Expression and mutations in squamous cell carcinoma of the head and neck: correlates with the patient's use of tobacco and alcohol. Cancer Detect Prev 18: 197-208
16. Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor suppressor gene. N Engl J Med 329:1318-1327
17. Hoffman B, Liebermann DA (1994) Molecular controls of apoptosis: differentiation/growth arrest primary response genes, protooncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene 9:1807-1812
18. Hollstein M, Sidransky D, Vogelstein B et al. (1991) p53 mutations in human cancers. Science 253:49-53
19. Kowe SW, Bodis S, McClatchey A et al. (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810
20. Lane DP (1992) p53, guardian of the genome. Nature 358:15-16
21. Lane DP (1993) A death in the life of p53. Nature 362:786-787
22. Langdon JD, Partridge M (1992) Expression of the tumour suppressor gene p53 in oral cancer. Br J Oral Maxillofac Surg 30:214-220
23. Lavielle JP, Brambilla E, Riva-Lavielle C et al. (1995) Immunhistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck. Acta Otolaryngol 115:334-339
24. Lee NK, Ye YW, Chen J et al. (1993) p53, retinoblastoma, and human papillomavirus in squamous cell carcinoma and adjacent normal mucosa of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg 119: 1125-1131
25. Levine AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene. Nature 351: 453-456
26. Marx J (1993) How p53 suppresses cell growth. Science 262:1644-1645
27. Miller C, Mohandas T, Wolf D et al. (1986) Human p53 localized to short arm of chromosome 17. Nature 319:783-784
28. Munck-Wikland E, Edstrom S, Jungmark E et al. (1994) Nuclear DNA content proliferating-cell nuclear (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. Int J Cancer 56:95-99
29. Nelson WG, Kastan MB (1994) DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 14:1815-1823
30. Ogden GR, Kiddie RA, Lunny OP et al. (1992) Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J Pathol 166:389-394
31. Pavelic ZP, Gluckman JL, Gapany M et al. (1992) Improved immunhistochemical detection of p53 protein in paraffin-embedded tissues reveals elevated levels in most head and neck and lung carcinomas: correlation with clinicopathological parameters. Anticancer Res 12:1389-1394
32. Sakai E, Rikimura K, Ueda M et al. (1992) The p53 tumour suppressor gene and ras oncogene mutations in oral squamous cell carcinoma. Int J Cancer 52:867-729
33. Sakai E, Tsuchida N (1992) Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene 7:927-933
34. Shin DM, Kim K, Ro JY et al. (1994) Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54: 321-326
35. Sidransky D (1996) Molecular markers in head and neck cancer. Abstracts International Conference on Head and Neck Cancer 28.7-1.8.96, Toronto, Canada, pp 509-515
36. Somers KD, Merrkk MA, Lopez ME et al. (1992) Frequent p53 mutations in head and neck cancer. Cancer Res 52:5997-6000
37. Soussi T, Caron de Fromentel C, May P (1990) Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5:945-952
38. Vogelstein B, Kinzler KW (1992) p53 function and dysfunction. Cell 70:523-526
39. Waga S, Hannon GJ, Beach D et al. (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578
40. Watling DL, Gown AM, Coltrera MD (1992) Overexpression of p53 in head and neck cancer. Head Neck 14:437-444